Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Most anti-HIV regimens include a non-nucleoside reverse transcriptase inhibitor (NNRTI);
however, some individuals fail on these regimens. The purpose of this study is to evaluate
the safety and effectiveness of the protease inhibitor (PI) lopinavir/ritonavir (LPV/r) in
HIV infected individuals who are failing an anti-HIV regimen that includes an NNRTI.
Phase:
N/A
Details
Lead Sponsor:
AIDS Clinical Trials Group
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Lopinavir Ritonavir Tenofovir